These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23273588)

  • 1. A randomized controlled pilot study of outcomes of strict allowance of fluid therapy in hyponatremic heart failure (SALT-HF).
    Albert NM; Nutter B; Forney J; Slifcak E; Tang WH
    J Card Fail; 2013 Jan; 19(1):1-9. PubMed ID: 23273588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
    Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
    J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new programme of multidisciplinary care for patients with heart failure in Poznań: one-year follow-up.
    Wierzchowiecki M; Poprawski K; Nowicka A; Kandziora M; Piatkowska A; Jankowiak M; Michałowicz B; Stawski W; Dziamska M; Kaszuba D; Szymanowska K; Michalski M
    Kardiol Pol; 2006 Oct; 64(10):1063-70; discussion 1071-2. PubMed ID: 17089238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salt and fluid restriction is effective in patients with chronic heart failure.
    Philipson H; Ekman I; Forslund HB; Swedberg K; Schaufelberger M
    Eur J Heart Fail; 2013 Nov; 15(11):1304-10. PubMed ID: 23787719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial.
    Aliti GB; Rabelo ER; Clausell N; Rohde LE; Biolo A; Beck-da-Silva L
    JAMA Intern Med; 2013 Jun; 173(12):1058-64. PubMed ID: 23689381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability.
    Travers B; O'Loughlin C; Murphy NF; Ryder M; Conlon C; Ledwidge M; McDonald K
    J Card Fail; 2007 Mar; 13(2):128-32. PubMed ID: 17395053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods.
    Ritter P; Delnoy PP; Padeletti L; Lunati M; Naegele H; Borri-Brunetto A; Silvestre J
    Europace; 2012 Sep; 14(9):1324-33. PubMed ID: 22549295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved health-related quality of life and functional status after surgical ventricular restoration.
    Sartipy U; Albåge A; Lindblom D
    Ann Thorac Surg; 2007 Apr; 83(4):1381-7. PubMed ID: 17383343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life assessment for acute heart failure patients from emergency department presentation through 30 days after discharge: a pilot study with the Kansas City Cardiomyopathy Questionnaire.
    Sauser K; Spertus JA; Pierchala L; Davis E; Pang PS
    J Card Fail; 2014 Jan; 20(1):18-22. PubMed ID: 24296380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
    Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
    Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does oxygen saturation or distance walked predict rehospitalization in heart failure?
    Howie-Esquivel J; Dracup K
    J Cardiovasc Nurs; 2008; 23(4):349-56. PubMed ID: 18596499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.
    Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does clinician's knowledge of B-type natriuretic peptide levels translate to improvement of quality of life and less hospitalization days in patients with heart failure?
    Ancheta IB; Evans M; Miller AB; Chiong JR; Battie C
    Prog Cardiovasc Nurs; 2009 Mar; 24(1):12-8. PubMed ID: 19261138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.
    Freeman JV; Masoudi FA
    Heart Fail Clin; 2013 Jan; 9(1):59-77. PubMed ID: 23168318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.